The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant loss of -62.03% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -41.38%. Over the past 30 days, the price of TXG has leaped by -6.80%. And in the last five days, it has fallen by -3.76%.
In terms of market performance, 10x Genomics Inc had a fairly uneven. The highest value for the stock in the past year was $57.90 on 12/20/23, and the lowest value was recorded at $15.28 on 07/10/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of TXG Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. 10x Genomics Inc’s current trading price is -63.30% away from its 52-week high, while its distance from the 52-week low is 39.07%. The stock’s price range during this time has been between $15.28 and $57.90. The trading volume for the Healthcare sector company’s shares reached about 1.35 million for the day, which was lower than the average daily volume of 1.86 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
10x Genomics Inc (TXG) has experienced a quarterly rise of 8.97% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.56B and boasts a workforce of 1259 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 21.46, with a change in price of -5.04. Similarly, 10x Genomics Inc recorded 1,692,757 in trading volume during the last 100 days, posting a change of -19.17%.
TXG’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TXG stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.11.
TXG Stock Stochastic Average
Today’s raw stochastic average for 10x Genomics Inc over the last 50 days is 58.75%.This indicates a increase from the raw stochastic average of the past 20 days, which was 8.12%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 31.50% and 41.30%, respectively.
